Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Insmed (INSM) Operating Leases (2019 - 2026)

Insmed's Operating Leases history spans 8 years, with the latest figure at $9.8 million for Q1 2026.

  • Quarterly Operating Leases rose 16.0% to $9.8 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $9.8 million through Mar 2026, up 16.0% year-over-year, with the annual reading at $12.2 million for FY2025, 33.6% up from the prior year.
  • Operating Leases came in at $9.8 million for Q1 2026, down from $12.2 million in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $19.9 million in Q1 2022 to a low of $7.6 million in Q3 2025.
  • The 5-year median for Operating Leases is $12.2 million (2025), against an average of $12.4 million.
  • The largest YoY upside for Operating Leases was 33.6% in 2025 against a maximum downside of 38.59% in 2025.
  • Insmed's Operating Leases stood at $14.9 million in 2022, then dropped by 25.85% to $11.0 million in 2023, then dropped by 17.26% to $9.1 million in 2024, then surged by 33.6% to $12.2 million in 2025, then decreased by 19.2% to $9.8 million in 2026.
  • Per Business Quant, the three most recent readings for INSM's Operating Leases are $9.8 million (Q1 2026), $12.2 million (Q4 2025), and $7.6 million (Q3 2025).